Keytruda (pembrolizumab) is an immunotherapy drug used to treat various types of cancer
Keytruda (pembrolizumab) is an immunotherapy drug used to treat various types of cancer. It is a monoclonal antibody that works by targeting the PD-1 (programmed death receptor-1) pathway, helping the immune system recognize and attack cancer cells. Uses of Keytruda Keytruda is FDA-approved for treating: Non-small cell lung cancer (NSCLC) Melanoma Head and neck squamous cell carcinoma Hodgkin lymphoma Bladder cancer Colorectal cancer (with microsatellite instability-high or mismatch repair deficiency) Cervical cancer Other cancers with specific genetic markers How It Works Cancer cells can evade immune system attacks by binding to PD-1 on T cells, effectively "turning off" the immune response. Keytruda blocks PD-1, allowing the immune system to detect and destroy cancer cells more effectively. Administration & Dosage Given as an intravenous (IV) infusion Typically administered every 3 to 6 weeks , depending on the condition Common Side Effects Fat...